fibrinogen has been researched along with Testicular Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiginger, P; Kuzmits, R; Schwarz, HP | 1 |
| Hilgard, P; Hossfeld, DK | 1 |
2 other study(ies) available for fibrinogen and Testicular Neoplasms
| Article | Year |
|---|---|
[Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antifibrinolytic Agents; Antineoplastic Agents; Antithrombin III; Complement C1 Inactivator Proteins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Multiple Myeloma; Neoplasm Metastasis; Plasminogen; Prostatic Neoplasms; Rhabdomyosarcoma; Testicular Neoplasms | 1981 |
Transient bleomycin-induced thrombocytopenia. A clinical study.
Topics: Adult; Bleomycin; Blood Cell Count; Blood Coagulation Tests; Bone Marrow Examination; Drug Therapy, Combination; Fibrinogen; Humans; Male; Testicular Neoplasms; Thrombocytopenia; Vinblastine | 1978 |